{name}
{subtitle}
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~18 mi. (Haine-Saint-Paul, Belgium, +150 more cities)
facility
Hopital de Jolimont ( Site 0103)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~18 mi. (Haine-Saint-Paul, Belgium, +142 more cities)
facility
Centre Hospitalier de Jolimont
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~20 mi. (Mons, Belgium, +176 more cities)
facility
C.I.U. Hopital Ambroise Pare ( Site 2039)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~20 mi. (Mons, Belgium, +147 more cities)
facility
C.I.U. Hopital Ambroise Pare ( Site 0353)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~20 mi. (Mons, Belgium, +122 more cities)
facility
C.I.U. Hopital Ambroise Pare ( Site 1001)
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
city
~21 mi. (Anderlecht, Belgium, +207 more cities)
facility
Institut Jules Bordet ( Site 0710)
biomarker
ER Positive, +1 more biomarker
drug
cyclophosphamide, +6 more drugs
drug type
chemotherapy, +3 more types
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~23 mi. (Brussels, Belgium, +192 more cities)
facility
UZ Brussel
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~23 mi. (Brussels, Belgium, +127 more cities)
facility
Université Libre de Bruxelles - Hôpital Erasme, +1 more facility
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type